News

High-cost specialty drugs continue to dominate the new drug landscape

June 26, 2018

The Patented Medicine Prices Review Board (PMPRB), through the National Prescription Drug Utilization Information System (NPDUIS) research initiative, today published the second annual edition of Meds Entry Watch.


New Patented Medicine Prices Review Board Chairperson announced

February 16, 2018

Dr. Mitchell Levine appointed as Chairperson of the Patented Medicine Prices Review Board


Canadian generic drug prices remain higher than international levels in recent years

February 6, 2018

The Patented Medicine Prices Review Board releases its latest report on generic drug pricing in Canada.


Patented Medicine Prices Review Board explores possible changes to how it conducts business

December 11, 2017

The Patented Medicine Prices Review Board (PMPRB) today published a scoping paper which provides its initial thoughts on how best to operationalize the Minister of Health’s proposed amendments to the Patented Medicines Regulations, which were published in the Canada Gazette, Part I on December 2, 2017.


Federal Minister of Health tables the 2016 Annual Report of the Patented Medicine Prices Review Board

October 27, 2017

The Honourable Ginette Petitpas Taylor, Federal Minister of Health, yesterday tabled the 2016 Annual Report of the Patented Medicine Prices Review Board (PMPRB) with the Clerks of the House of Commons and the Senate.


PAGE 1 - 2 - 3 - 4 - 5  NEXT 25  LAST 5 
Date modified: